HSBC UK and Sage have unveiled 'My Business Finances', a new digital tool embedded within the bank's platform to help sole traders and landlords comply with upcoming Making Tax Digital (MTD) for Income Tax rules, streamlining invoicing, bookkeeping, and tax filing in one place.
Prime Minister Keir Starmer's landmark visit to Beijing marks a cautious pivot in UK-China relations, yielding agreements on tariffs, visas, and green energy. But can British businesses navigate the opportunities and challenges of re-engagement?
Drivers across the Midwest are feeling the pinch as average gasoline prices rose for a second consecutive week, with regional costs now sitting significantly below the national average.
At its Analyst Day, Korro Bio detailed its lead candidate KRRO-121, an RNA-editing therapeutic designed to tackle hyperammonemia in urea cycle disorders and hepatic encephalopathy by stabilizing a key liver enzyme, positioning it as a potential paradigm shift from current burdensome treatments.
In its Q4 2025 earnings call, SL Green Realty projected strong fundamentals for Manhattan's office market, citing robust leasing and AI-driven demand. Management reiterated ambitious 2026 financing and asset sale targets while reporting quarterly results that beat expectations.
Citizens reiterates a 'Market Outperform' rating and $396 price target for BeOne Medicines (ONC), driven by robust Phase 3 trial results in gastric cancer. The firm highlights the company's strong pipeline and cash position as key growth drivers.
Biotech firm Argenx SE sees its flagship drug Vyvgart outperform sales expectations in myasthenia gravis and CIDP treatments, with analysts pointing to sustained growth and regulatory momentum as key drivers.
Fractyl Health's Revita procedure shows promise in maintaining weight after stopping GLP-1 drugs, with new six-month data prompting the company to seek a streamlined FDA pathway. A packed 2026 roadmap aims for a U.S. submission, but financial pressures loom.
As trillion-dollar AI infrastructure spending fuels concerns of a market bubble, long-term investors are questioning whether broad index funds like the Vanguard S&P 500 ETF still offer a safe harbor.
As volatility returns to European markets, investors are turning to dividend-paying stocks for income and stability. We examine three companies with compelling, yet distinct, dividend profiles for income-focused portfolios.
Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.
First Internet Bancorp (INBK) reported a robust 21% surge in quarterly revenue, successfully managing an uptick in criticized loans while laying the groundwork for growth in its fintech and SBA lending segments for the coming year.
Shares of Liberty Energy (LBRT) surged over 16% to an all-time peak as CEO Ron Gusek's aggressive growth roadmap, targeting a tripling of power demand, overshadowed a sharp decline in annual profits.
Bitcoin plunged to a nine-month low as a confluence of political uncertainty and geopolitical tensions sparked a broad market sell-off, forcing over $1.6 billion in leveraged positions to close.
A brutal sell-off wiped nearly $10,000 from Bitcoin's value, pushing it perilously close to its November low. The sharp decline, which triggered over $1.75 billion in liquidations, coincides with speculation of a major leadership change at the U.S. Federal Reserve.
As gold spot prices post their largest single-day dollar gain on record, economist Peter Schiff warns that U.S. equities are in a deep, prolonged bear market when measured against the precious metal, highlighting a stark divergence in asset performance.
Elevra Lithium reports record quarterly revenue from its flagship North American operation but tempers near-term production guidance, highlighting the complex balancing act facing lithium miners as they expand amid market volatility.
British pharmaceutical giant AstraZeneca has entered a strategic partnership with China's CSPC Pharmaceutical, committing over $1 billion upfront to co-develop next-generation obesity therapies, signaling intensified competition in the lucrative global weight-loss drug market.
In a turbulent session driven by geopolitical fears, gold staged a historic V-shaped recovery while Bitcoin languished, raising fresh questions about the cryptocurrency's viability as a modern safe haven.
In a landmark move, Venezuela's parliament has passed reforms to its hydrocarbons law, easing state control and aiming to lure back foreign capital to its struggling oil industry, coinciding with a partial easing of U.S. sanctions.
